Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Comparison of Human and Mouse Interleukins Reveals Link

By LabMedica International staff writers
Posted on 05 Feb 2019
A study comparing the structure and function of human and mouse interleukins revealed a close link between protein folding and immune regulation.

Interleukins are small, secreted proteins that drive immune cell communication. More...
Understanding how cells produce interleukins is considered to be critical for decoding and modulating immune responses. An example of particular complexity and biological relevance is the interleukin 12 (IL-12) family. Four functionally distinct alpha-beta heterodimers are assembled from only five subunits to regulate immune cell function and development. In addition, some subunits act as independent signaling molecules. In particular, IL-27 is composed of two subunits, alpha and beta. In humans, these have to assemble to form bioactive IL-27, whereas in mice, IL-27alpha can be secreted alone, modulating immune reactions and reducing sepsis-related mortality.

Investigators at the Technical University of Munich (Germany) reported in the January 16, 2019, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America that differences in a single amino acid determined if IL-27alpha could be secreted autonomously, acting as a signaling molecule, or if it depended on hetero-dimerization for secretion.

By combining computer simulations with biochemical experiments, the investigators dissected the underlying structural determinants: a protein folding switch coupled to disulfide bond formation regulated chaperone-mediated retention versus secretion.

Using these insights the investigators changed folding and assembly control for this protein. This provided the basis for a more human-like IL-27 system in mice and established a secretion-competent human IL-27alpha that signaled on its own and could regulate immune cell function.

"The interleukins are the vocabulary with which immune cells communicate," explained Dr. Matthias Feige, professor of cellular protein biochemistry at the Technical University of Munich. "The cells form these messenger molecules according to a very specific blueprint of individual amino acids. Their arrangement determines, which three-dimensional structure an interleukin adopts and, consequently, which information it transmits. Our approach allowed us to rationally extend the language of immune cells by engineering a key signaling molecule. This provides us with an opportunity to modulate the reaction of immune cells in a targeted manner."

Related Links:
Technical University of Munich


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.